CoQ10 and Aging
The aging process includes impairment in mitochondrial function, a reduction in anti-oxidant activity, and an increase in oxidative stress, marked by an increase in reactive oxygen species (ROS) production. Oxidative damage to macromolecules including DNA and electron transport proteins likely incre...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/8/2/28 |
id |
doaj-7ee8a64e62ea4a9d9c2cf32eca688edf |
---|---|
record_format |
Article |
spelling |
doaj-7ee8a64e62ea4a9d9c2cf32eca688edf2020-11-24T21:29:03ZengMDPI AGBiology2079-77372019-05-01822810.3390/biology8020028biology8020028CoQ10 and AgingIsabella Peixoto de Barcelos0Richard H. Haas1Department of Neurosciences, University of California San Diego, San Diego, CA 92093-0935, USADepartment of Neurosciences, University of California San Diego, San Diego, CA 92093-0935, USAThe aging process includes impairment in mitochondrial function, a reduction in anti-oxidant activity, and an increase in oxidative stress, marked by an increase in reactive oxygen species (ROS) production. Oxidative damage to macromolecules including DNA and electron transport proteins likely increases ROS production resulting in further damage. This oxidative theory of cell aging is supported by the fact that diseases associated with the aging process are marked by increased oxidative stress. Coenzyme Q10 (CoQ<sub>10</sub>) levels fall with aging in the human but this is not seen in all species or all tissues. It is unknown whether lower CoQ<sub>10</sub> levels have a part to play in aging and disease or whether it is an inconsequential cellular response to aging. Despite the current lay public interest in supplementing with CoQ<sub>10</sub>, there is currently not enough evidence to recommend CoQ<sub>10</sub> supplementation as an anti-aging anti-oxidant therapy.https://www.mdpi.com/2079-7737/8/2/28coenzyme Q10agingage-related diseasesmitochondrial dysfunction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Isabella Peixoto de Barcelos Richard H. Haas |
spellingShingle |
Isabella Peixoto de Barcelos Richard H. Haas CoQ10 and Aging Biology coenzyme Q10 aging age-related diseases mitochondrial dysfunction |
author_facet |
Isabella Peixoto de Barcelos Richard H. Haas |
author_sort |
Isabella Peixoto de Barcelos |
title |
CoQ10 and Aging |
title_short |
CoQ10 and Aging |
title_full |
CoQ10 and Aging |
title_fullStr |
CoQ10 and Aging |
title_full_unstemmed |
CoQ10 and Aging |
title_sort |
coq10 and aging |
publisher |
MDPI AG |
series |
Biology |
issn |
2079-7737 |
publishDate |
2019-05-01 |
description |
The aging process includes impairment in mitochondrial function, a reduction in anti-oxidant activity, and an increase in oxidative stress, marked by an increase in reactive oxygen species (ROS) production. Oxidative damage to macromolecules including DNA and electron transport proteins likely increases ROS production resulting in further damage. This oxidative theory of cell aging is supported by the fact that diseases associated with the aging process are marked by increased oxidative stress. Coenzyme Q10 (CoQ<sub>10</sub>) levels fall with aging in the human but this is not seen in all species or all tissues. It is unknown whether lower CoQ<sub>10</sub> levels have a part to play in aging and disease or whether it is an inconsequential cellular response to aging. Despite the current lay public interest in supplementing with CoQ<sub>10</sub>, there is currently not enough evidence to recommend CoQ<sub>10</sub> supplementation as an anti-aging anti-oxidant therapy. |
topic |
coenzyme Q10 aging age-related diseases mitochondrial dysfunction |
url |
https://www.mdpi.com/2079-7737/8/2/28 |
work_keys_str_mv |
AT isabellapeixotodebarcelos coq10andaging AT richardhhaas coq10andaging |
_version_ |
1725967694072643584 |